cefazoline

It is an antibiotic used to treat infections caused by bacteria, particularly infections of the bronchi (such as bronchitis or exacerbations of chronic bronchitis), the throat (pharyngitis), the tonsils (tonsillitis), the skin, soft tissues, and non-serious urinary tract infections.

Form: tablets, modified release

ATC: J01DC04

Manufacturer: EG S.P.A.

The drug is an antibiotic indicated for the treatment of various infections, including acute bronchitis and exacerbation of chronic bronchitis, pharyngitis, tonsillitis, skin and soft tissue infections, lower urinary tract infections (such as cystitis or pyelonephritis), otitis media, sinusitis, and gonococcal urethritis.

Form: tablets, modified release

ATC: J01DC04

Manufacturer: NEW RESEARCH S.R.L.

This medicine is indicated for the treatment of more severe forms of acute bronchitis, exacerbation of chronic bronchitis, pharyngitis, tonsillitis, skin and soft tissue infections, and uncomplicated lower urinary tract infections.

Form: granules for oral suspension

ATC: J01DC04

Manufacturer: PIAM FARMACEUTICI S.P.A.

This medicinal product is an antibiotic indicated for the treatment of infections caused by sensitive bacteria, such as those of the respiratory tract (pneumonia, bronchitis, pharyngitis, tonsillitis), skin and soft tissue infections, and urinary tract infections.

Form: tablets, modified release

ATC: J01DC04

Manufacturer: LANOVA FARMACEUTICI S.R.L.